14-102376694-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_014844.5(TECPR2):c.-28G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000472 in 1,602,996 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0022 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00029 ( 0 hom. )
Consequence
TECPR2
NM_014844.5 5_prime_UTR_premature_start_codon_gain
NM_014844.5 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.129
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 14-102376694-G-A is Benign according to our data. Variant chr14-102376694-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 509723.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0022 (335/152248) while in subpopulation AFR AF= 0.00753 (313/41558). AF 95% confidence interval is 0.00685. There are 3 homozygotes in gnomad4. There are 158 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TECPR2 | NM_014844.5 | c.-28G>A | 5_prime_UTR_premature_start_codon_gain_variant | 2/20 | ENST00000359520.12 | NP_055659.2 | ||
TECPR2 | NM_014844.5 | c.-28G>A | 5_prime_UTR_variant | 2/20 | ENST00000359520.12 | NP_055659.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECPR2 | ENST00000359520 | c.-28G>A | 5_prime_UTR_premature_start_codon_gain_variant | 2/20 | 1 | NM_014844.5 | ENSP00000352510.7 | |||
TECPR2 | ENST00000359520 | c.-28G>A | 5_prime_UTR_variant | 2/20 | 1 | NM_014844.5 | ENSP00000352510.7 |
Frequencies
GnomAD3 genomes AF: 0.00222 AC: 338AN: 152130Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
338
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000503 AC: 126AN: 250744Hom.: 1 AF XY: 0.000450 AC XY: 61AN XY: 135516
GnomAD3 exomes
AF:
AC:
126
AN:
250744
Hom.:
AF XY:
AC XY:
61
AN XY:
135516
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000290 AC: 421AN: 1450748Hom.: 0 Cov.: 28 AF XY: 0.000275 AC XY: 199AN XY: 722574
GnomAD4 exome
AF:
AC:
421
AN:
1450748
Hom.:
Cov.:
28
AF XY:
AC XY:
199
AN XY:
722574
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00220 AC: 335AN: 152248Hom.: 3 Cov.: 32 AF XY: 0.00212 AC XY: 158AN XY: 74424
GnomAD4 genome
AF:
AC:
335
AN:
152248
Hom.:
Cov.:
32
AF XY:
AC XY:
158
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 31, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at